Company / Interest Expense
TG Therapeutics, Inc. Interest Expense History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$12.6M
FY2023
5-year range
$5.6M / $12.6M
FY2019-FY2023
Trend
+23.8%
vs FY2022
Sector context
#24 of 44
Health Care
What the data says
At $13M, TG Therapeutics, Inc.'s interest expense ranks #21 of 44 in the Health Care sector. Interest Expense has fluctuated over the past 7 years, ranging from $845,000 in FY2019 to $13M in FY2023.
Based on SEC 10-K filings.
$13M in FY2023 with a 5-year CAGR of +70.4%.
Increased from $6M to $13M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +25.8%
- 5-Year CAGR
- +70.4%
- 10-Year CAGR
- -
Sector benchmark
#21 of 44 in Health CareTop 45% of 44This company $12.6M Sector average $291.0M
▼
-95.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +70.4%, indicating consistent growth.
- In FY2023, interest expense increased 23.8% year-over-year.
- Ranks #24 out of 44 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $12.6M | +23.8% |
| FY2022 | $10.2M | +80.8% |
| FY2021 | $5.6M | -10.9% |
| FY2020 | $6.3M | +649.0% |
| FY2019 | $845.0K | -3.6% |
| FY2018 | $877.0K | +3.8% |
| FY2017 | $845.0K | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026